We Are Large in Size but Entrepreneurial in Culture

FIL is one of the largest private, independent investment management organisations in the world. Our two affiliated companies, FIL Ltd and FMR LLC operate in 35 countries and FIL has had a presence in Asia since 1969.

Despite the size and scale of our organisation, Fidelity remains extremely entrepreneurial in culture. We have consistently shown a keen interest in working only with the most dynamic and capable entrepreneurs around the world. In China, FAV has a long track record of backing some of the country's technology pioneers at the early, start-up phase of their companies.

We Have a Long and Successful Track Record of Investing Globally

For 40 years, Fidelity Ventures (www.fidelityventures.com) has been among the top-tier venture capital investors in North America and Europe, investing over US$1.5 billion in over 100 technology companies including some of the world's most successful technology companies such as Atari, Continental Cablevision, MCI, Nextel, Teleport Communications and ROLM.

Based in Cambridge, the city that is home to both Harvard University and MIT, Fidelity Biosciences (www.fidelitybiosciences.com) focuses on high-potential opportunities in biotechnology and life sciences.

In Asia, the Fidelity Asia Ventures team has been investing in private companies over the past 14 years. Notable successful investments include: AsiaInfo, Hurray, Alibaba, Pharmanex, and Wuxi Pharmatech. Our investment track record is one of the most successful in the industry, and our reputation and relationships among leading technology entrepreneurs in Greater China are second to none.

We Invest in Both Information Technology and Healthcare

Fidelity Asia Ventures is one of the few venture capital investment operations in Asia with a track record and expertise in both the information technology and healthcare sectors.

Our investment professionals apply their deep industry knowledge to assist our portfolio companies to develop new business opportunities, recruit senior executives and explore promising strategic options. We also regularly tap into the collective wisdom of our industry-specific US affiliates, Fidelity Ventures and Fidelity Biosciences, as well as the deep technology and operations resources throughout Fidelity's global operations.

We Invest Our Own Capital

Unlike almost all other venture capital firms, FAV invests Fidelity's own proprietary capital and does not manage funds on behalf of third-party investors. As a result, we do not spend time on fundraising, nor do we have artificial fund deadlines that limit our investment horizon. We believe that having a more patient and long-term view is critical to successful venture investing, especially in Asia.

Moreover, all of our investment professionals are required to put in their own capital alongside that of Fidelity's for any investment. Thus we are all focused, along with the entrepreneur, on a common objective - to maximum business success and long-term wealth creation.